Laserfiche WebLink
HF100 NINTH ENGROSSMENT REVISOR BD 1-10100-9 <br />257.1 industrial hemp or added to industrial hemp during any production or processing stages of <br />257.2 any batch from which a representative sample has been sent for testing, including any <br />257.3 catalysts used to create artificially derived cannabinoids. Disclosure must be made to the <br />257.4 laboratory performing testing or sampling and, upon request, to the commissioner. Disclosure <br />257.5 must include all information known to the licensee regardless of whether the application or <br />257.6 addition was made intentionally or accidentally, or by the manufacturer or any other person. <br />257.7 (Ja)_Lc) Upon the request of the bed commissioner, the manufacturer of the product <br />257.8 must provide the bead commissioner with the results of the testing required in this section. <br />257.9 (d) The commissioner may determine that any testing laboratory that does not operate <br />257.10 formal management systems under the International Organization for Standardization is not <br />257.11 an accredited laboratory and require that a representative sample of a batch of the product <br />257.12 be retested by a testing laboratory that meets this requirement. <br />257.13 (O_Le) Testing of the hemp from which the nonintoxicating cannabinoid was derived, <br />257.14 or possession of a certificate of analysis for such hemp, does not meet the testing requirements <br />257.15 of this section. <br />257.16 Subd. 5. Labeling requirements. (a) A product regulated under this section must bear <br />257.17 a label that contains, at a minimum: <br />257.18 (1) the name, location, contact phone number, and website of the manufacturer of the <br />257.19 product; <br />257.20 (2) the name and address of the independent, accredited laboratory used by the <br />257.21 manufacturer to test the product; and <br />257.22 (3) the batch number; and <br />257.23 (3,)_(4) an accurate statement of the amount or percentage of cannabinoids found in each <br />257.24 unit of the product meant to be consumed. <br />257.25 (b) The information in paragraph (a) may be provided on an outer package if the <br />257.26 immediate container that holds the product is too small to contain all of the information. <br />257.27 (c) The information required in paragraph (a) may be provided through the use of a <br />257.28 scannable barcode or matrix barcode that links to a page on the manufacturer's website if <br />257.29 that page contains all of the information required by this subdivision. <br />257.30 (d) The label must also include a statement stating that the product does not claim to <br />257.31 diagnose, treat, cure, or prevent any disease and has not been evaluated or approved by the <br />257.32 United States Food and Drug Administration (FDA) unless the product has been so approved. <br />Article 7 Sec. 2. 257 <br />